CD34+Cell Dose Is the Major Cell Dose Determinant of Myeloid Engraftment After Single Umbilical Cord Blood Transplantation (sUCBT) for Adult Patients with High-Risk Hematologic Malignancies

被引：0
|
作者：
Sanz, Jaime [1 ]
Montesinos, Pau [1 ]
Martinez, David [1 ]
Lorenzo, Ignacio [1 ]
Palau, Javier [1 ]
Larrea, Luis [2 ]
Planelles, Dolores [2 ]
Martin, Guillermo [1 ]
Jarque, Isidro [1 ]
De La Rubia, Javier [1 ]
Moscardo, Federico [1 ]
Martinez, Jesus [1 ]
Angel Sanz, Miguel [1 ]
Sanz, Guillermo F. [1 ]
机构：
[1] Hosp Univ La Fe, Valencia, Spain
[2] Ctr Transfus Comunidad Valenciana, Valencia, Spain
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：574 / 574
页数：1
相关论文
共 50 条
  • [31] Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantation
    Mielcarek, Marco
    Storer, Barry E.
    Flowers, Mary E. D.
    Storb, Rainer
    Sandmaier, Brenda M.
    Martin, Paul J.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2007, 13 (10) : 1160 - 1168
  • [32] PROCESSING CRYOPRESERVED LOW CELL DOSE UMBILICAL CORD BLOOD FOR ADULT TRANSPLANTATION WITH MINIMAL MANIPULATION AND CELL LOSS: A SINGLE INSTITUTION EXPERIENCE
    Parthasarathy, M.
    Rodriguez, T.
    Smith, S.
    Lu, S.
    Stiff, P.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 43 - 43
  • [33] Impact of total nucleated (TNC) and CD34+cell dose on different outcomes after double unrelated cord blood transplantation in patients with haematological malignancies. An analysis on behalf of the SFGM-TC and Eurocord
    Michallet, M.
    Cunha, R.
    Michel, G.
    Socie, G.
    Mohty, M.
    Rio, B.
    Blaise, D.
    Sirvent, A.
    Bordigoni, P.
    Deconinck, E.
    Yakoub-Agha, I.
    Rossi, J. -F.
    Maillard, N.
    Tabrizi, R.
    Ruggeri, A.
    Sobh, M.
    Gluckman, E.
    Milpied, N.
    Rocha, V.
    [J]. BONE MARROW TRANSPLANTATION, 2011, 46 : S12 - S12
  • [34] Higher CD34 Cell Dose Is Associated with Improved 5-Year Survival after Peripheral Blood Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies
    Gauntner, Timothy D.
    Cao, Qing
    Warlick, Erica
    El Jurdi, Najla
    Bachanova, Veronika
    Rashidi, Armin
    Brunstein, Claudio G.
    Holtan, Shernan
    He, Fiona
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S281 - S281
  • [35] Sitagliptin Improves Engraftment and Platelet Recovery After Single Unit, Very Low Cell Dose Cord Blood Transplantation
    Georges, George E.
    Lesnikov, Vladimir
    Jordan, Robert
    Aragon, Anna
    Yang, Ya-Ju Laura
    Lesnikova, Marina
    [J]. BLOOD, 2011, 118 (21) : 1278 - 1279
  • [36] Predictive value for engraftment and survival of total nucleated cell dose (TNC) as compared to CD34+ cell dose after autologous and allogeneic bone marrow transplant (BMT) for hematologic malignancies.
    Kassim, AA
    Mineishi, S
    Jagasia, M
    Vurisikala, M
    Goodman, S
    Greer, JP
    Chinratanalab, W
    Ruffner, K
    Morgan, DS
    Stein, RS
    Brandt, S
    Schuening, FG
    [J]. BLOOD, 2004, 104 (11) : 346B - 346B
  • [37] Precise measurements of post-processing CD34+cell dose at a single site improves cord blood unit selection.
    Alonso, J. F.
    Regan, D. M.
    Wofford, J. D.
    Oliver, D. A.
    Creer, M. H.
    [J]. CYTOTHERAPY, 2006, 8
  • [38] Cryopreserved CD34+ Cell Dose, but Not Total Nucleated Cell Dose, Influences Hematopoietic Recovery and Extensive Chronic Graft-versus-Host Disease after Single-Unit Cord Blood Transplantation in Adult Patients
    Konuma, Takaaki
    Kato, Seiko
    Oiwa-Monna, Maki
    Tanoue, Susumu
    Ogawa, Miho
    Isobe, Masamichi
    Tojo, Arinobu
    Takahashi, Satoshi
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (07) : 1142 - 1150
  • [39] CD34+cell dose predicts relapse and survival after T-cell-depleted HLA-identical haematopoietic stem cell transplantation (HSCT) for haematological malignancies
    Bahçeci, E
    Read, EJ
    Leitman, S
    Childs, R
    Dunbar, C
    Young, NS
    Barrett, AJ
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2000, 108 (02) : 408 - 414
  • [40] Minimal myelosuppressive conditioning and allogeneic blood stem cell transplantation in high-risk patients with hematologic malignancies.
    Kobbe, G
    Schneider, P
    Aivado, M
    Zohren, F
    Schubert, D
    Fenk, R
    Neumann, F
    Kronenwett, R
    Pape, H
    Germing, U
    Gattermann, N
    Heyll, A
    Haas, R
    [J]. BLOOD, 2001, 98 (11) : 318B - 318B
12345